A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer - Related Studies

A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00437268. Last updated on August 6, 2008. Information provided by Eli Lilly and Company

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer
		Colorectal Carcinoma
		Colorectal Tumor

2	Additional conditions recognized in this trial
		Carcinoma
		Colorectal Neoplasms

3	More general conditions related to this trial
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Rectal Diseases

4	Interventions listed in this trial
		enzastaurin
		irinotecan
		cetuximab

5	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Eli Lilly and Company